(Q52926328)

9 May 2018

title

Poor efficacy of amphotericin B-based therapy in CNS aspergillosis. (English)

1 reference

9 May 2018

2

Markus Ruhnke

1 reference

9 May 2018

author name string

Stefan Schwartz

1

1 reference

9 May 2018

Patricia Ribaud

3

1 reference

9 May 2018

Elizabeth Reed

4

1 reference

9 May 2018

Peter Troke

5

1 reference

9 May 2018

Eckhard Thiel

6

1 reference

9 May 2018

publication date

1 May 2007

1 reference

9 May 2018

published in

Mycoses

1 reference

9 May 2018

volume

50

1 reference

9 May 2018

issue

3

1 reference

9 May 2018

page(s)

196-200

1 reference

9 May 2018

Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01345.X

Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01345.X

Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01345.X

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01345.X

Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01345.X

Localization of aspergillosis to the central nervous system among patients with acute leukemia: report of 14 cases. Gruppo Italiano Malattie Ematologiche dell'Adulto Infection Program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01345.X

Improved outcome in central nervous system aspergillosis, using voriconazole treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01345.X

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01345.X

Tissue concentrations and bioactivity of amphotericin B in cancer patients treated with amphotericin B-deoxycholate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01345.X

Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01345.X

Treatment of cerebral Aspergillosis with itraconazole: do high doses improve the prognosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01345.X

High-dose itraconazole for the treatment of cerebral aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01345.X

Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01345.X

Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01345.X

Fungal infections in cancer patients: an international autopsy survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01345.X

Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01345.X

Fungal brain abscess in transplant recipients: epidemiologic, microbiologic, and clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2007.01345.X

10.1111/J.1439-0507.2007.01345.X

21 January 2018

Identifiers

DOI

1 reference

9 May 2018

1 reference

9 May 2018